Australian telehealth software leader Coviu raises A$6 million in its latest funding round as it turns its attention towards accelerating health digitalisation and international expansion
Posts about Australia:
Speech pathologists and psychologists across Australia & New Zealand will now be able to conduct a valid remote clinical assessment via a telehealth consult from the Coviu platform.
Coviu is proud to announce the integration with Rosemary Health is now live and available for use on the platform.
PHA, the Australian private health insurance industry’s peak representative body, currently oversees 24 health funds and 97% of all Australian's covered by private health insurance.
Universal telehealth rebates have finally arrived in Australia in what Prime Minister Scott Morrison declared “is a decade's worth of work in a matter of days.”
At Coviu, we understand almost 70% of Australia's healthcare funding is provided via the government. This means that reimbursements for telehealth are essential for patient and provider uptake.
Sydney, 20 February: As the physical rebuild continues across mainland Australia following one of the worst bushfire seasons on record - for many, the mental scars are only just emerging.
The World Health Organisation has declared the spread of novel coronavirus (2019-nCoV/COVID-19) a global emergency, following its appearance in China late last year. As of February 12, over 45 000 cases and 1,100 deaths have been confirmed in mainland China alone, surpassing the toll from the SARS epidemic of 2002-3.
The 2019-20 bushfire season has been catastrophic, and there is no clear end in sight. So far, 4 people have lost their lives, over 400 homes have been destroyed and countless pets and wildlife have perished. Even as residents slowly return to their homes or communities, many adults and children will continue to experience poor mental health due to sheer loss and grief.
Aims to bring more interactive digital consultations to the healthcare sector
SYDNEY AUSTRALIA — 18th April 2018. Coviu, a spinout of CSIRO’s Data61, has raised $1m from venture capital firm Main Sequence Ventures to provide Australians with greater access to interactive medical treatment in the comfort of their own home.